Fernanda Orsi Explores Brazilian Registry of Thrombotic Thrombocytopenic Purpura
Fernanda Orsi, Associate Professor at Faculty of Medical Sciences, Unicamp, shared on LinkedIn:
”I am always happy to share my work and new insightful publications.
However, this one comes with a bitter taste.
In this prospective study, we show that the diagnosis and treatment of thrombotic thrombocytopenic purpura (TTP) in Brazil are more than 10 years outdated, negatively affecting disease prognosis.
Forty percent of patients don’t have access to ADAMTS13 testing; more than 10% don’t receive therapeutic plasma exchange, and half don’t receive rituximab.
In-hospital mortality is high (15%). TTP management is still challenging in Brazil, as it likely is in other low- and middle-income countries.
It is difficult to look at these numbers and not call for action, both to promote medical education for earlier recognition of the disease and to improve access to appropriate healthcare.”
Read the full article here.
Article: Brazilian Registry of Thrombotic Thrombocytopenic Purpura: A prospective cohort study of diagnosis, management and outcomes in Brazil
Authors: Thaís Nóbrega, Tiago Boechat, Denys Fujimoto, Sibia Marcondes, Silvia Bueno, Suzanna Tavares, Alessandra Prezotti, Juliana Duarte, Fabiana Piassi, Lucas Cesped, Erica Okazaki, Bianca Stefanello, Carolina Costa-Lima, Paula Villaça, Fernanda Orsi
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 11, 2026, 17:41Khaled Musallam: Earlier Recognition, Better Outcomes in NTDT
-
Sep 11, 2026, 17:29Reyhan Kose Cobanoglu: APS ACTION Registry Study Published in Lupus
-
Sep 11, 2026, 17:14Obi Light Ogbonnia: From Kenya to Global Sickle Cell Advocacy
-
Sep 11, 2026, 17:01EAHAD 2027 Marks 20 Years
-
Sep 11, 2026, 16:54Denise Braendgaard: Reimagining Health Systems Through Collective Action
-
Sep 11, 2026, 16:47Jehad Khamaysa: Budd-Chiari Syndrome as the Initial Presentation of Behçet’s Disease in a 16-Year-Old
-
Sep 11, 2026, 16:44Mostafa Faisal Mohammed Saleh: From HLA Biology to Curative Therapy
-
Sep 11, 2026, 16:38Jim Kaveney: Class I, Level A – Lifestyle is Now the Official Standard in AFib Care
-
Sep 11, 2026, 16:31George Touma: Do We Really Need to Implant Metal in Every High-Bleeding-Risk Patient?